NEW YORK (GenomeWeb) – Thermo Fisher Scientific has announced a strategic partnership with Cytonome/ST, a Boston-based cell sorting technology company, to co-develop a flow cytometry technology.
Under the terms of the agreement, Thermo Fisher will also be the exclusive distributor of this new technology.
Financial and other terms of the agreement were not disclosed.
"We are extremely impressed with the quality and remarkable ease-of-use of Cytonome's bench-top cell-sorter platform," Valerie Bressler-Hill, Thermo Fisher's VP and general manager of flow cytometry, said in a statement.
The deal offers another opportunity for Thermo Fisher to grow its cellular analysis business. The firm acquired Affymetrix in January, which included the eBioscience unit's portfolio of antibodies and assays.